29th September 2016
It was announced today that Sahajanand Medical Technologies (SMT) is to establish its European headquarters which will have a state-of-the-art Research, Development and Innovation Centre in Galway, creating 50 jobs over five years.
The project is supported by the Department of Jobs, Enterprise & Innovation through IDA Ireland.
SMT is largest developer and manufacturer of minimally invasive coronary stent systems in India and supplies to around 60 countries in Europe, Asia, MENA and Latin America.
SMT has received numerous awards for its breakthrough innovations and quality that have led to more thinner and flexible DES with good long term clinical results.
Speaking at today’s announcement, SMT’s Western European Head, Mr. Gaurav Goel said: “We were pioneers among Indian medical device companies to identify tremendous value in investing in research & development (R&D). Our core strength lies in our ability to excel in developing technologically complex products through focused teams. With this centre, we hope to tap into the excellent talent pool available in Galway to make further enhancements in existing products and to develop new and innovative products.”
Welcoming the new SMT project, Minister for Jobs, Enterprise & Innovation, Mary Mitchell O Connor TD said: "I am delighted by the new initiative and warmly welcome the investment being made by SMT, with the creation of 50 new jobs in Galway. It will build on our existing expertise in the Medical Devices sector. This new headquarters is very welcome in a regional location in Galway, and this dovetails with the Government's commitment to the provision of quality jobs in locations away from the main cities, driven by our successful Regional Action Plan for Jobs process".
Minister of State for Gaeltacht Affairs and Natural Resources, Sean Kyne TD, who attended today’s announcement, said: "The decision by SMT to choose Galway as its European headquarters and create 50 jobs is a further vote of confidence in the City and County which has deservedly earned a reputation as a medical technologies hub. Companies such as SMT, which are pioneers in their fields, are attracted to Galway and the West for many reasons, not least the strong, vibrant and varied research being undertaken at our local higher education institutions."
IDA Ireland’s CEO Martin Shanahan said: “I am delighted to welcome SMT to Galway. This is an important win for the West Region in line with our strategy to promote investment in regional locations. It will act as a valuable reference seller for us in attracting other companies in the Medical Technologies sector to the region. I wish Gaurav and his team here in Galway every success.”
For information on the new roles go to: http://www.hero.ie/smtjobs
About the company
Established in the year 1998, SMT became the first indigenous player in India to successfully launch coronary stent. It is India's largest stent manufacturing company and sells its product in more than 60 countries across the world and employs over 400 people. The Company is ISO 9001 and ISO 13485 certified & it has also obtained CE certification for all of its products
SMT has been recognised with numerous awards including the 2016 National Award for Innovation and Technology for its use of biodegradable polymers in Medical Technologies and the India Healthcare Excellence Award for Medical Devices Company of the Year. SMT is the first company in the world to receive CE certification for its drug-eluting stents with biodegradable polymers, which established a new industry trend. The company was also the first in the world to receive CE certification for its drug-eluting stent technology using ultrathin (60µ) strut thickness and was again the first to introduce blended biodegradable polymers to increase stent flexibility and durability.
Contact
For details of our current job openings please see http://www.hero.ie/smtjobs
For all other enquiries please email Ireland@sahmed.com
IDA Ireland
Regional Communications, Press & PR Executive Ellen Lynch
+353 87 4112084 ellen.lynch@ida.ie
Back to Department News